Connect with us

Politics

Why China-Bashing Dominates U.S. Elections?

Published

11 years ago

on

It isn’t the first time that China has been involved in the heated conversation in US Presidential elections. For many years, it has been linked to the US during the election times. All the three presidential debates between Mitt Romney and Barack Obama made no exceptions.

During the 1st presidential debate, Mitt Romney described China, not once, but 3 times in response to domestic economy and trade, touting that the US should surpass China in sales and not balance deficits and expenses through Chinese loans. In the 2nd debate, Barack Obama claimed that the United States couldn’t fall behind Chinese slow growth of new energy, accusing his challenger, Mitt Romney of investing in the firm that produces components for China to track American citizens.

In the third debate that focused on the foreign policy again brought China in picture and how to manage with difficulties brought by China’s growth became a separate debate topic. Both have blamed China for the high unemployment rate and weak economy in the US.

All the presidential contenders have argued over China and took a strong stance in past thirty years. Nevertheless, how strong they are, the China bashing statements in the elections are silly. Regardless of who wins the battle, every US president exceptionally gives a significant importance to the US-China relationship. China bashing in other word is a topic that attracts voter’s attention. Repetition of the topic signifies that the dramatic elements of foreign relations in the election campaigns and debate. Hence, political forecasters believe that instead of taking China bashing too seriously during the election, it is more important to deal with US-China relations after the election.

It’s against the scene of universal concern for economy and livelihood among the electoral voters that the contenders pay much attention to China and its economy and its impact on the United States, explaining that China has an increasing effect on the US economy as well as politics.  About 2/3rd of Americans believe that China and the US share good relations, while 55% of people say that the US should maintain the strong and stable connection with China, according to the opinion poll conducted by one of the US organizations. Hence, giving the equal importance of US-China relations, whoever wins the election can’t implement negative China policies and the complexity of two-sided connections calculates that the United States will never be very close to China.

Related Topics:
Continue Reading

Market

Special News: National Bank of Greece (ADR)(NYSE:NBG), Seadrill Ltd(NYSE:SDRL), Teck Resources Ltd (USA) (NYSE:TCK)

Published

9 years ago

on

December 18, 2014

By

Lakeway, NY — (MARKET NEWS CALL) — 12/18/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on National Bank of Greece (ADR)(NYSE:NBG), Seadrill Ltd(NYSE:SDRL), Teck Resources Ltd (USA) (NYSE:TCK).

National Bank of Greece (ADR)(NYSE:NBG)’s shares gained 10.56% to $1.99. The 52 week trading range for the company is $1.76 – $5.98. The shares of the company plunged 65% in the last one year. The company is a Greece-based financial institution. It provides a range of financial services including retail and commercial banking, asset management, brokerage, investment banking, insurance and real estate at a global level. Its segments are: Retail Banking, Corporate and Investment Banking, Global Markets and Asset Management and International Banking Operations.

Should Investors Buy NBG After The Recent Development? Find Out Here

Seadrill Ltd(NYSE:SDRL) shares jumped 10.55% to $12.16. Levi & Korsinsky on Dec. 16 announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Seadrill Limited American Depository Receipts (“ADRs”) between July 10, 2014 and November 25, 2014. The complaint alleges that Seadrill issued materially false and misleading information to the investing public. In particular, the complaint alleges that the Company issued statements suggesting that the Company would maintain its dividend until at least the end of 2015, but then on November 26, 2014, the Company disclosed it would indefinitely suspend its dividend, citing Seadrill’s need to pay down its debt to strengthen its balance sheet.

Is SDRL Going To Rise or Fall After Today’s Price Action? Find Out Here

Teck Resources Ltd (USA) (NYSE:TCK)’s shares jumped 10.46% to $12.36. The company on Dec. 17 announced the first shipment of zinc and lead in concentrate from its restarted Pend Oreille Operations in northeastern Washington State to its nearby Trail Operations in British Columbia for processing.

Can Traders Buy TCK After The Solid Rally? Get Free Trend Analysis Here

“The restart of our Pend Oreille zinc mine was completed on time and under budget and allows us to grow our zinc production at a time when global supply is constrained,” said Don Lindsay, President and CEO. “We are pleased to be operating again in Washington State and helping to support jobs and economic activity in the community, region and state.”

About thenextbigtrade.com

thenextbigtrade.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. thenextbigtrade.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed “informational edge” which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.

Disclaimer

The assembled information disseminated by thenextbigtrade.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. thenextbigtrade.com does expect that investors will buy and sell securities based on information assembled and presented in thenextbigtrade.com. PLEASE always do your own due diligence, and consult your financial advisor.

Continue Reading

Politics

Stocks Highlights: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), StemCells Inc. (NASDAQ:STEM), Geron Corporation (NASDAQ:GERN)

Published

10 years ago

on

July 11, 2014

By

StemCells Inc. (NASDAQ:STEM)’s shares declined 2.42% to $2.02. The company on July 7 announced the appointment of Alan Trounson, Ph.D. to its Board of Directors. Dr. Trounson most recently served as President of The California Institute of Regenerative Medicine (CIRM), the largest scientific funding body for stem cell research in the world. Dr. Trounson has been the recipient of over 30 awards and distinctions for his scientific work, including pioneering work in the fields of in-vitro fertilization and stem cells. As part of his academic research, Dr. Trounson pioneered a new stem cell biology approach for the treatment of a broad range of diseases and injuries, which was awarded the first ever Australian Center of Excellence in Biotechnology grant worth $110 million dollars.

Get the Inside Scoop On STEM here with this Free Report

Synta Pharmaceuticals Corp. (NASDAQ:SNTA)’s shares decreased 4.48% to $4.37. The 52 week trading range for the company is $3.70 – $7.85. The company is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. As of December 31, 2011, it had two drug candidates in clinical trials for treating multiple types of cancer and several drug candidates in the preclinical-stage of development.

You won’t believe what we found out about SNTA

Geron Corporation (NASDAQ:GERN)’s shares dropped 0.68% and closed at $2.91. The company on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of imetelstat. In order to resolve the partial clinical hold, the investigator, Dr. Ayalew Tefferi of Mayo Clinic, Rochester, Minnesota, was required to provide follow-up information regarding reversibility of hepatotoxicity for all patients who received imetelstat in the Myelofibrosis IST. In its letter dated June 11, 2014, the FDA informed the investigator that it had completed the review of his complete response submission and concluded that the Myelofibrosis IST may proceed.

Why Should You Buy GERN Now? Get The Free Trend Analysis Here

 

Continue Reading

Politics

Hot Stocks Alert: Walter Energy, Inc. (NYSE:WLT), AK Steel Holding Corporation (NYSE:AKS), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Published

10 years ago

on

June 20, 2014

By

Walter Energy, Inc. (NYSE:WLT)’s shares gained 0.73% to $5.55. Walter Energy’s stock price target was lowered to $3 from $5 at Goldman on June 6 and reiterates its Sell rating citing downside risk to its met coal price forecast.

 WLT Move Over there Is A New Social Media Stock In Town. Read More Here

Additionally, the company on June 2 issued the following statement this morning regarding the release of EPA’s CO2 emission limits regulations for existing power plants: “Because the rules issued by EPA are aimed at controlling CO2 emissions from existing domestic power plants, we do not expect the regulation will have any material impact on Walter Energy. We primarily mine and sell metallurgical grades of coal that are used in making steel, not generating electricity. Approx. 95% of the company’s coal-related revenues come from the export of metallurgical coal.”

AK Steel Holding Corporation (NYSE:AKS)’s shares dropped 2.11% to $7.44. The company on June 11 said that it plans to release its second quarter 2014 financial results before the opening of trading on the New York Stock Exchange on July 29, 2014.

Is It The Perfect Time To Reshuffle Your Portfolio With This Multibagger? Find Out Here

Additionally, the company on June 19 provided guidance for its second quarter 2014 financial results.  AK Steel said it expects to report a net loss of $0.19 to $0.23 per diluted share of common stock, which is a substantial improvement over its first quarter results.  Adjusted to exclude the loss of $0.17 per diluted share for mark-to-market losses on derivatives, the company’s adjusted net loss for the second quarter would be $0.02 to $0.06 per diluted share.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares gained 0.31% to $6.57. The company announced that its Annual Meeting of Stockholders will be webcast live on June 25, 2014.

Don’t Repeat The Mistake By Not Including This Multibagger In Your Portfolio? Grab The Stock Ideas Here

Additionally, the company on June 12 announced the pricing of $200 million aggregate principal amount of its 3.625% convertible senior notes due 2019 (the “Notes”) in a private placement. The Notes will be offered by the initial purchasers only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”).

Continue Reading
Advertisement

Trending